{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=582","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=580","results":[{"created":"2023-07-10T19:53:20.196554+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.108","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mef2c has been classified as Green List (High Evidence).","entity_name":"MEF2C","entity_type":"gene"},{"created":"2023-07-10T19:53:13.228510+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.108","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MEF2C as Green List (high evidence)","entity_name":"MEF2C","entity_type":"gene"},{"created":"2023-07-10T19:53:13.202333+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.108","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mef2c has been classified as Green List (High Evidence).","entity_name":"MEF2C","entity_type":"gene"},{"created":"2023-07-10T19:52:05.998549+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.107","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MOCS1 as ready","entity_name":"MOCS1","entity_type":"gene"},{"created":"2023-07-10T19:52:05.988196+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.107","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mocs1 has been classified as Amber List (Moderate Evidence).","entity_name":"MOCS1","entity_type":"gene"},{"created":"2023-07-10T19:52:00.374997+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.107","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MOCS1 as Amber List (moderate evidence)","entity_name":"MOCS1","entity_type":"gene"},{"created":"2023-07-10T19:52:00.362510+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.107","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mocs1 has been classified as Amber List (Moderate Evidence).","entity_name":"MOCS1","entity_type":"gene"},{"created":"2023-07-10T19:50:39.805686+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.106","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MCOLN1 as ready","entity_name":"MCOLN1","entity_type":"gene"},{"created":"2023-07-10T19:50:39.797275+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.106","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mcoln1 has been classified as Green List (High Evidence).","entity_name":"MCOLN1","entity_type":"gene"},{"created":"2023-07-10T19:50:34.391174+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.106","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MCOLN1 as Green List (high evidence)","entity_name":"MCOLN1","entity_type":"gene"},{"created":"2023-07-10T19:50:34.379110+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.106","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mcoln1 has been classified as Green List (High Evidence).","entity_name":"MCOLN1","entity_type":"gene"},{"created":"2023-07-10T19:34:19.273875+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.105","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAST1 as ready","entity_name":"MAST1","entity_type":"gene"},{"created":"2023-07-10T19:34:19.253460+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.105","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mast1 has been classified as Amber List (Moderate Evidence).","entity_name":"MAST1","entity_type":"gene"},{"created":"2023-07-10T19:34:10.365153+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.105","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MAST1 as Amber List (moderate evidence)","entity_name":"MAST1","entity_type":"gene"},{"created":"2023-07-10T19:34:10.357321+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.105","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mast1 has been classified as Amber List (Moderate Evidence).","entity_name":"MAST1","entity_type":"gene"},{"created":"2023-07-10T19:32:38.628343+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.207","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FGFR3 as ready","entity_name":"FGFR3","entity_type":"gene"},{"created":"2023-07-10T19:32:38.617467+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.207","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fgfr3 has been classified as Amber List (Moderate Evidence).","entity_name":"FGFR3","entity_type":"gene"},{"created":"2023-07-10T19:32:32.982407+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.207","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FGFR3 as Amber List (moderate evidence)","entity_name":"FGFR3","entity_type":"gene"},{"created":"2023-07-10T19:32:32.974724+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.207","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fgfr3 has been classified as Amber List (Moderate Evidence).","entity_name":"FGFR3","entity_type":"gene"},{"created":"2023-07-10T19:32:21.092987+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.206","user_name":"Zornitza Stark","item_type":"entity","text":"gene: FGFR3 was added\ngene: FGFR3 was added to Clefting disorders. Sources: Expert Review\nMode of inheritance for gene: FGFR3 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: FGFR3 were set to 22565872; 29150894; 37010288\nPhenotypes for gene: FGFR3 were set to Muenke syndrome, OMIM:602849; Hypochondroplasia, OMIM:146000\nReview for gene: FGFR3 was set to AMBER\nAdded comment: Although there are more than three unrelated cases reported with cleft lip and/or palate, this is not consistently found in individuals with monoallelic variants in FGFR3 gene.\r\n\r\nPMID:22565872 included 21 individuals with variants in FGFR3 and presenting with Muenke syndrome in this study, of which 16 had structural anomaly of the palate. However, only one patient had cleft lip and palate.\r\n\r\nPMID:29150894 reported a father and two children with FGFR3 variant and presenting with hypochondroplasia, of which only the daughter had cleft palate.\r\n\r\n2 out of 15 individuals reported in DECIPHER database with monoallelic sequence variants had cleft palate. \nSources: Expert Review","entity_name":"FGFR3","entity_type":"gene"},{"created":"2023-07-10T19:28:44.562294+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.205","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CNTNAP1 as ready","entity_name":"CNTNAP1","entity_type":"gene"},{"created":"2023-07-10T19:28:44.547414+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.205","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cntnap1 has been classified as Green List (High Evidence).","entity_name":"CNTNAP1","entity_type":"gene"},{"created":"2023-07-10T19:28:37.821938+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.205","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CNTNAP1 as Green List (high evidence)","entity_name":"CNTNAP1","entity_type":"gene"},{"created":"2023-07-10T19:28:37.810770+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.205","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cntnap1 has been classified as Green List (High Evidence).","entity_name":"CNTNAP1","entity_type":"gene"},{"created":"2023-07-10T19:28:26.222189+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.204","user_name":"Zornitza Stark","item_type":"entity","text":"gene: CNTNAP1 was added\ngene: CNTNAP1 was added to Clefting disorders. Sources: Expert Review\nMode of inheritance for gene: CNTNAP1 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: CNTNAP1 were set to 28374019; 29511323; 29882456; 37010288\nPhenotypes for gene: CNTNAP1 were set to Hypomyelinating neuropathy, congenital, 3, OMIM:618186\nReview for gene: CNTNAP1 was set to GREEN\nAdded comment: There is sufficient evidence (3 unrelated cases) for the association of biallelic variants in this gene with cleft palate.\r\n\r\nPMID:28374019 - Cleft palate was reported in two children from a large Israeli consanguineous family of Palestinian ancestry with a homozygous stop-gain variant in CNTNAP1(c.2015G>A/ p.Trp672Ter).\r\n\r\nPMID:29511323/ 37010288 - There is one individual reported with compound heterozygous stop gain variants in CNTNAP1 (c.2687G​>A/ p.Trp896Ter & c.1861C​>T/ p.Arg621Ter) had cleft palate from DECIPHER database.\r\n\r\nPMID:29882456 - An eight year old American male patient with a homozygous CNTNAP1 variant (c.1163G>C/ p.Arg388Pro) had cleft palate. \nSources: Expert Review","entity_name":"CNTNAP1","entity_type":"gene"},{"created":"2023-07-10T19:25:35.231409+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.203","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ARID1B as ready","entity_name":"ARID1B","entity_type":"gene"},{"created":"2023-07-10T19:25:35.222835+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.203","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: arid1b has been classified as Amber List (Moderate Evidence).","entity_name":"ARID1B","entity_type":"gene"},{"created":"2023-07-10T19:25:16.166157+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.203","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ARID1B as Amber List (moderate evidence)","entity_name":"ARID1B","entity_type":"gene"},{"created":"2023-07-10T19:25:16.156565+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.203","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: arid1b has been classified as Amber List (Moderate Evidence).","entity_name":"ARID1B","entity_type":"gene"},{"created":"2023-07-10T19:25:03.361616+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.202","user_name":"Zornitza Stark","item_type":"entity","text":"gene: ARID1B was added\ngene: ARID1B was added to Clefting disorders. Sources: Expert Review\nMode of inheritance for gene: ARID1B was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: ARID1B were set to 30349098; 37010288\nPhenotypes for gene: ARID1B were set to Coffin-Siris syndrome 1, OMIM:135900\nReview for gene: ARID1B was set to AMBER\nAdded comment: Although there are more than three unrelated cases with ARID1B monoallelic variants reported with either cleft palate, cleft uvula or bifid uvula, clefting is not consistently present in individuals with ARID1B variants.\r\n\r\nPMID:30349098 - On this web-based survey based on previously reported features of individuals with variants in ARID1B gene (143 in total), which also included submissions to DECIPHER database, two individuals were identified with cleft palate, one with cleft uvula, two with bifid uvula and three with sub mucous cleft. Although variants identified in these patients are reported in this publication, there is no association of individual patients to phenotypes available.\r\n\r\nOf >100 patients with ARID1B variants in the DECIPHER database, only one patient (c.3183_3184​insT/ p.Tyr1062LeufsTer10) was reported with submucous cleft soft palate and two patients (c.4155_4156​insA/ p.Asn1386LysfsTer18 & c.2620+5G​>A) were reported with bifid uvula. \nSources: Expert Review","entity_name":"ARID1B","entity_type":"gene"},{"created":"2023-07-10T19:22:36.217696+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CHD4 as ready","entity_name":"CHD4","entity_type":"gene"},{"created":"2023-07-10T19:22:36.203226+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: chd4 has been classified as Amber List (Moderate Evidence).","entity_name":"CHD4","entity_type":"gene"},{"created":"2023-07-10T19:22:29.447138+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CHD4 as Amber List (moderate evidence)","entity_name":"CHD4","entity_type":"gene"},{"created":"2023-07-10T19:22:29.439047+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: chd4 has been classified as Amber List (Moderate Evidence).","entity_name":"CHD4","entity_type":"gene"},{"created":"2023-07-10T19:22:18.139902+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.200","user_name":"Zornitza Stark","item_type":"entity","text":"gene: CHD4 was added\ngene: CHD4 was added to Clefting disorders. Sources: Expert Review\nMode of inheritance for gene: CHD4 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: CHD4 were set to 31388190; 37010288\nPhenotypes for gene: CHD4 were set to Sifrim-Hitz-Weiss syndrome, MIM 617159\nReview for gene: CHD4 was set to AMBER\nAdded comment: Although there are four unrelated cases presenting with either cleft palate and/or bifid uvula, this phenotype is not consistent among patients identified with monoallelic variants in CHD4 gene. \r\n\r\nPMID:31388190 reported 32 patients with heterozygous variants in CHD4 gene, of which one individual (p.Gln715Ter) had cleft palate and Pierre Robin sequence. In addition, another individual identified with heterozygous variant p.Arg1127Gln was reported with bifid uvula.\r\n\r\nIn addition, 2 out of 10 individuals with pathogenic/ likely pathogenic heterozygous variants from the DDD study were reported with cleft palate in addition to several other clinical presentations including global developmental delay (PMID:37010288). \nSources: Expert Review","entity_name":"CHD4","entity_type":"gene"},{"created":"2023-07-10T19:19:22.125556+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: B4GALT7 as ready","entity_name":"B4GALT7","entity_type":"gene"},{"created":"2023-07-10T19:19:22.114073+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: b4galt7 has been classified as Amber List (Moderate Evidence).","entity_name":"B4GALT7","entity_type":"gene"},{"created":"2023-07-10T19:19:16.777707+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: B4GALT7 were changed from EHLERS-DANLOS SYNDROME WITH SHORT STATURE AND LIMB ANOMALIES; EDSSLA to Ehlers-Danlos syndrome, spondylodysplastic type, 1, MIM# 130070","entity_name":"B4GALT7","entity_type":"gene"},{"created":"2023-07-10T19:18:59.333314+10:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.198","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: B4GALT7: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Ehlers-Danlos syndrome, spondylodysplastic type, 1, MIM# 130070; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"B4GALT7","entity_type":"gene"},{"created":"2023-07-10T19:16:49.980837+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.169","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DNAJC3 as ready","entity_name":"DNAJC3","entity_type":"gene"},{"created":"2023-07-10T19:16:49.972829+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.169","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnajc3 has been classified as Green List (High Evidence).","entity_name":"DNAJC3","entity_type":"gene"},{"created":"2023-07-10T19:16:43.669131+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.169","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DNAJC3 were changed from Cerebellar ataxia, neuropathy with SNCV, hearing loss, diabetes mellitus to Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, MIM# 616192","entity_name":"DNAJC3","entity_type":"gene"},{"created":"2023-07-10T19:16:19.682854+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.168","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: DNAJC3 were set to 25466870","entity_name":"DNAJC3","entity_type":"gene"},{"created":"2023-07-10T19:15:38.683577+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.167","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DDHD1 as ready","entity_name":"DDHD1","entity_type":"gene"},{"created":"2023-07-10T19:15:38.675431+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.167","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ddhd1 has been classified as Amber List (Moderate Evidence).","entity_name":"DDHD1","entity_type":"gene"},{"created":"2023-07-10T19:15:08.166288+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.167","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DDHD1 as Amber List (moderate evidence)","entity_name":"DDHD1","entity_type":"gene"},{"created":"2023-07-10T19:15:08.151805+10:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.167","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ddhd1 has been classified as Amber List (Moderate Evidence).","entity_name":"DDHD1","entity_type":"gene"},{"created":"2023-07-10T19:12:55.773106+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.104","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MLC1 as ready","entity_name":"MLC1","entity_type":"gene"},{"created":"2023-07-10T19:12:55.762087+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.104","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mlc1 has been classified as Red List (Low Evidence).","entity_name":"MLC1","entity_type":"gene"},{"created":"2023-07-10T19:12:48.141061+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.104","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MLC1 as Red List (low evidence)","entity_name":"MLC1","entity_type":"gene"},{"created":"2023-07-10T19:12:48.132826+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.104","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mlc1 has been classified as Red List (Low Evidence).","entity_name":"MLC1","entity_type":"gene"},{"created":"2023-07-10T19:10:54.665069+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.103","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: WDR26 as ready","entity_name":"WDR26","entity_type":"gene"},{"created":"2023-07-10T19:10:54.657814+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.103","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: wdr26 has been classified as Green List (High Evidence).","entity_name":"WDR26","entity_type":"gene"},{"created":"2023-07-10T19:10:48.272148+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.103","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: WDR26 as Green List (high evidence)","entity_name":"WDR26","entity_type":"gene"},{"created":"2023-07-10T19:10:48.253719+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.103","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: wdr26 has been classified as Green List (High Evidence).","entity_name":"WDR26","entity_type":"gene"},{"created":"2023-07-10T19:10:02.933890+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.102","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: WWOX as ready","entity_name":"WWOX","entity_type":"gene"},{"created":"2023-07-10T19:10:02.924862+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.102","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: wwox has been classified as Green List (High Evidence).","entity_name":"WWOX","entity_type":"gene"},{"created":"2023-07-10T19:09:56.659453+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.102","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: WWOX as Green List (high evidence)","entity_name":"WWOX","entity_type":"gene"},{"created":"2023-07-10T19:09:56.645899+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.102","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: wwox has been classified as Green List (High Evidence).","entity_name":"WWOX","entity_type":"gene"},{"created":"2023-07-10T19:09:03.737155+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.497","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MLH1 as ready","entity_name":"MLH1","entity_type":"gene"},{"created":"2023-07-10T19:09:03.723968+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.497","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mlh1 has been classified as Red List (Low Evidence).","entity_name":"MLH1","entity_type":"gene"},{"created":"2023-07-10T19:08:37.584072+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.497","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MSH2 as ready","entity_name":"MSH2","entity_type":"gene"},{"created":"2023-07-10T19:08:37.573203+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.497","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: msh2 has been classified as Red List (Low Evidence).","entity_name":"MSH2","entity_type":"gene"},{"created":"2023-07-10T19:08:17.161840+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.497","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MSH6 as ready","entity_name":"MSH6","entity_type":"gene"},{"created":"2023-07-10T19:08:17.148064+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.497","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: msh6 has been classified as Red List (Low Evidence).","entity_name":"MSH6","entity_type":"gene"},{"created":"2023-07-10T19:07:38.647228+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.101","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KMT2B were changed from Dystonia 28, childhood-onset - #617284 to Dystonia 28, childhood-onset MIM#617284; Intellectual developmental disorder, autosomal dominant MIM#619934","entity_name":"KMT2B","entity_type":"gene"},{"created":"2023-07-10T19:07:06.653472+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.100","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: KMT2B were set to 29697234","entity_name":"KMT2B","entity_type":"gene"},{"created":"2023-07-10T19:06:22.648570+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.99","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: KMT2B as Green List (high evidence)","entity_name":"KMT2B","entity_type":"gene"},{"created":"2023-07-10T19:06:22.640277+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.99","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kmt2b has been classified as Green List (High Evidence).","entity_name":"KMT2B","entity_type":"gene"},{"created":"2023-07-10T19:04:52.825328+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.98","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KCNT1 as ready","entity_name":"KCNT1","entity_type":"gene"},{"created":"2023-07-10T19:04:52.814433+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.98","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kcnt1 has been classified as Green List (High Evidence).","entity_name":"KCNT1","entity_type":"gene"},{"created":"2023-07-10T19:04:33.131471+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.98","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: KCNT1 as Green List (high evidence)","entity_name":"KCNT1","entity_type":"gene"},{"created":"2023-07-10T19:04:33.120221+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.98","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kcnt1 has been classified as Green List (High Evidence).","entity_name":"KCNT1","entity_type":"gene"},{"created":"2023-07-10T19:03:33.077660+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.97","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KCNB1 as ready","entity_name":"KCNB1","entity_type":"gene"},{"created":"2023-07-10T19:03:33.068907+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.97","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kcnb1 has been classified as Red List (Low Evidence).","entity_name":"KCNB1","entity_type":"gene"},{"created":"2023-07-10T19:03:26.961875+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.97","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: KCNB1 as Red List (low evidence)","entity_name":"KCNB1","entity_type":"gene"},{"created":"2023-07-10T19:03:26.954658+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.97","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kcnb1 has been classified as Red List (Low Evidence).","entity_name":"KCNB1","entity_type":"gene"},{"created":"2023-07-10T19:01:44.771179+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.96","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KAT6A as ready","entity_name":"KAT6A","entity_type":"gene"},{"created":"2023-07-10T19:01:44.752289+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.96","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kat6a has been classified as Green List (High Evidence).","entity_name":"KAT6A","entity_type":"gene"},{"created":"2023-07-10T19:01:38.759272+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.96","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: KAT6A as Green List (high evidence)","entity_name":"KAT6A","entity_type":"gene"},{"created":"2023-07-10T19:01:38.748483+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.96","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kat6a has been classified as Green List (High Evidence).","entity_name":"KAT6A","entity_type":"gene"},{"created":"2023-07-10T19:00:52.295789+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.95","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: IRF2BPL as ready","entity_name":"IRF2BPL","entity_type":"gene"},{"created":"2023-07-10T19:00:52.278037+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.95","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: irf2bpl has been classified as Green List (High Evidence).","entity_name":"IRF2BPL","entity_type":"gene"},{"created":"2023-07-10T19:00:46.364265+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.95","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IRF2BPL as Green List (high evidence)","entity_name":"IRF2BPL","entity_type":"gene"},{"created":"2023-07-10T19:00:46.348019+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.95","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: irf2bpl has been classified as Green List (High Evidence).","entity_name":"IRF2BPL","entity_type":"gene"},{"created":"2023-07-10T18:58:49.025240+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.94","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: IQSEC2 were set to 33368194; 20473311; 23674175","entity_name":"IQSEC2","entity_type":"gene"},{"created":"2023-07-10T18:58:03.836250+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.93","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IQSEC2 as Amber List (moderate evidence)","entity_name":"IQSEC2","entity_type":"gene"},{"created":"2023-07-10T18:58:03.825982+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.93","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: iqsec2 has been classified as Amber List (Moderate Evidence).","entity_name":"IQSEC2","entity_type":"gene"},{"created":"2023-07-10T18:56:33.072101+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.92","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: IFIH1 as ready","entity_name":"IFIH1","entity_type":"gene"},{"created":"2023-07-10T18:56:33.061419+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.92","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ifih1 has been classified as Green List (High Evidence).","entity_name":"IFIH1","entity_type":"gene"},{"created":"2023-07-10T18:56:28.984866+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.92","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: IFIH1 were changed from Aicardi-Goutieres syndrome 7 MIM#615846; Immunodeficiency 95 MIM#619773; Singleton-Merten syndrome MIM#182250 to Aicardi-Goutieres syndrome 7 MIM#615846","entity_name":"IFIH1","entity_type":"gene"},{"created":"2023-07-10T18:55:55.040937+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.91","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IFIH1 as Green List (high evidence)","entity_name":"IFIH1","entity_type":"gene"},{"created":"2023-07-10T18:55:55.029160+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.91","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ifih1 has been classified as Green List (High Evidence).","entity_name":"IFIH1","entity_type":"gene"},{"created":"2023-07-10T18:54:45.499592+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.90","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HUWE1 as ready","entity_name":"HUWE1","entity_type":"gene"},{"created":"2023-07-10T18:54:45.486850+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.90","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: huwe1 has been classified as Red List (Low Evidence).","entity_name":"HUWE1","entity_type":"gene"},{"created":"2023-07-10T18:54:34.199843+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.90","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HUWE1 as Red List (low evidence)","entity_name":"HUWE1","entity_type":"gene"},{"created":"2023-07-10T18:54:34.183749+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.90","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: huwe1 has been classified as Red List (Low Evidence).","entity_name":"HUWE1","entity_type":"gene"},{"created":"2023-07-10T18:53:31.094471+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.89","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HPRT1 as ready","entity_name":"HPRT1","entity_type":"gene"},{"created":"2023-07-10T18:53:31.087212+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.89","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hprt1 has been classified as Green List (High Evidence).","entity_name":"HPRT1","entity_type":"gene"},{"created":"2023-07-10T18:53:17.669631+10:00","panel_name":"Cerebral Palsy","panel_id":73,"panel_version":"1.89","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HPRT1 as Green List (high evidence)","entity_name":"HPRT1","entity_type":"gene"}]}